NYSE - Delayed Quote • USD
CVS Health Corporation (CVS)
At close: April 18 at 4:00 PM EDT
After hours: April 18 at 7:57 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 22 | 22 | 26 | 25 |
| Avg. Estimate | 1.61 | 2.08 | 7.82 | 8.63 |
| Low Estimate | 1.53 | 1.83 | 7.64 | 8.38 |
| High Estimate | 1.9 | 2.2 | 7.91 | 8.97 |
| Year Ago EPS | 2.2 | 2.21 | 8.23 | 7.82 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 18 | 18 | 23 | 23 |
| Avg. Estimate | 83.99B | 86.71B | 349.14B | 369.69B |
| Low Estimate | 82.31B | 84.74B | 342.33B | 361.56B |
| High Estimate | 85.85B | 88.02B | 355.28B | 379.06B |
| Year Ago Sales | 80.81B | 88.92B | 336.84B | 349.14B |
| Sales Growth (year/est) | 3.90% | -2.50% | 3.70% | 5.90% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 2.09 | 2.11 | 2.13 | 1.87 |
| EPS Actual | 2.2 | 2.21 | 2.21 | 2 |
| Difference | 0.11 | 0.1 | 0.08 | 0.13 |
| Surprise % | 5.30% | 4.70% | 3.80% | 7.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.61 | 2.08 | 7.82 | 8.63 |
| 7 Days Ago | 1.71 | 2.22 | 8.3 | 9.18 |
| 30 Days Ago | 1.71 | 2.22 | 8.31 | 9.22 |
| 60 Days Ago | 1.75 | 2.2 | 8.33 | 9.23 |
| 90 Days Ago | 2.03 | 2.21 | 8.52 | 9.37 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | 1 | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | CVS | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -26.80% | -- | -- | 0.80% |
| Next Qtr. | -5.90% | -- | -- | 9.60% |
| Current Year | -5.00% | -- | -- | 4.50% |
| Next Year | 10.40% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 3.48% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 4.31% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 4/10/2024 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 4/8/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 4/4/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 3/15/2024 |
| Initiated | Barclays: Equal-Weight | 3/6/2024 |
| Initiated | Leerink Partners: Outperform | 2/26/2024 |
Related Tickers
HUM Humana Inc.
324.83
+0.42%
UNH UnitedHealth Group Incorporated
493.18
+2.96%
CNC Centene Corporation
73.75
+2.43%
CI The Cigna Group
348.78
+0.78%
ELV Elevance Health, Inc.
525.19
+3.19%
MOH Molina Healthcare, Inc.
360.94
+0.30%
OSCR Oscar Health, Inc.
16.45
+5.86%
CLOV Clover Health Investments, Corp.
0.6311
+1.51%
NEUE NeueHealth, Inc.
6.31
+8.05%
ALHC Alignment Healthcare, Inc.
5.10
+3.03%